HR 3493 · in committee · major
Global Fairness in Drug Pricing Act

Sponsor · D-CA-17
Ro Khanna
Citizen cosponsors
0
In Congress
7/ 435
House Reps cosponsoring
Introduced 2025-05-19
Joining the bill
Legislative timeline
2025-05-19 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-05-19 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-05-19 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-05-19 · IntroReferral
Introduced in House
2025-05-19 · IntroReferral
Introduced in House

Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.